E
Telo Genomics Corp. TELO.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -52.12% -40.52% -48.20% -32.08% 66.29%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -26.01% -19.20% -31.20% -13.07% 30.37%
Operating Income 26.01% 19.20% 31.20% 13.07% -30.37%
Income Before Tax 28.52% 19.17% 31.19% 14.48% -30.37%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 28.52% 19.17% 31.19% 14.48% -30.37%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 28.52% 19.17% 31.19% 14.48% -30.37%
EBIT 26.01% 19.20% 31.20% 13.07% -30.37%
EBITDA 25.44% 18.73% 31.40% 13.36% -30.29%
EPS Basic 33.72% 22.86% 40.78% 28.41% -8.86%
Normalized Basic EPS 33.33% 22.73% 40.63% 27.27% -8.00%
EPS Diluted 17.44% 2.67% 40.78% 15.91% -8.86%
Normalized Diluted EPS 33.33% 22.73% 40.63% 27.27% -8.00%
Average Basic Shares Outstanding 7.66% 4.56% 15.61% 19.20% 19.99%
Average Diluted Shares Outstanding 7.66% 4.56% 15.61% 19.20% 19.99%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings